BioLife Solutions, Inc. Cash and Restricted Cash
BioLife Solutions, Inc. (BLFS) had Cash and Restricted Cash of $29.48 million as of 2025-09-30, per its 10-Q filed 2025-11-06.
Financial Statements › Cash Flow › Cash
us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents · last filed 2025-11-06
- 2025-09-30: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $29.48M.
- 2025-06-30: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $31.90M.
- 2025-03-31: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $66.94M.
- 2024-12-31: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $95.39M.
| Period end | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents as first filed |
|---|---|---|
| 2025-09-30 | $29.48M 10-Q · filed 2025-11-06 | |
| 2025-06-30 | $31.90M 10-Q · filed 2025-08-07 | |
| 2025-03-31 | $66.94M 10-Q · filed 2025-05-08 | |
| 2024-12-31 | $95.39M 10-Q · filed 2025-11-06 | |
| 2024-09-30 | $24.16M 10-Q · filed 2025-11-06 | |
| 2024-06-30 | $22.05M 10-Q · filed 2025-08-07 | |
| 2024-03-31 | $29.73M 10-Q · filed 2025-05-08 | |
| 2023-12-31 | $35.44M 10-Q · filed 2025-11-06 | |
| 2023-09-30 | $19.27M 10-Q · filed 2024-11-12 | |
| 2023-06-30 | $21.43M 10-Q · filed 2024-08-09 | |
| 2023-03-31 | $19.14M 10-Q · filed 2024-05-10 | |
| 2022-12-31 | $19.47M 10-Q · filed 2024-11-12 | |
| 2022-09-30 | $27.07M 10-Q · filed 2023-11-09 | |
| 2022-06-30 | $24.03M 10-Q · filed 2023-08-09 | |
| 2022-03-31 | $59.50M 10-Q · filed 2022-05-10 | |
| 2021-12-31 | $69.87M 10-Q · filed 2023-11-09 | |
| 2021-09-30 | $75.10M 10-Q · filed 2021-11-15 | |
| 2021-06-30 | $76.20M 10-Q · filed 2021-08-16 | |
| 2021-03-31 | $89.00M 10-Q · filed 2021-05-17 | |
| 2020-12-31 | $90.46M 10-K · filed 2022-03-31 | |
| 2020-09-30 | $109.00M 10-Q · filed 2020-11-09 | |
| 2019-12-31 | $6.45M 10-K · filed 2022-03-31 | $6.40M 10-Q · filed 2020-11-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Axogen, Inc. (AXGN) | United States | $2.329B | -73.83 |
| CONMED Corp (CNMD) | United States | $1.353B | 26.72 |
| Ceribell, Inc. (CBLL) | United States | $0.916B | -11.27 |
| TransMedics Group, Inc. (TMDX) | United States | $2.911B | 15.17 |
| CapsoVision, Inc (CV) | United States | $0.310B | -12.68 |
| Electromed, Inc. (ELMD) | United States | $0.233B | 31.13 |
| EDAP TMS SA (FOCL) | $0.171B | ||
| Stereotaxis, Inc. (STXS) | United States | $0.130B | -7.53 |
| Vivani Medical, Inc. (VANI) | United States | $0.111B | |
| electroCore, Inc. (ECOR) | United States | $0.102B |